Ferritin nanoparticle complex with porcine epidemic diarrhea virus spike protein induces neutralizing antibody response against PEDV in mouse models
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von M S B W T M Nipuna Sudaraka Tennakoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Infectious Diseases, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea. Hauptthemen laut MEDLINE: Porcine epidemic diarrhea virus, Spike Glycoprotein, Coronavirus, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Ministry of SMEs and Startups, National Research Foundation of Korea.
Abstract (Originalsprache)
As the spike protein is the major antigen that contains various neutralizing epitopes against porcine epidemic diarrhea virus (PEDV), numerous vaccine trials employing the spike protein have been established. In this study, we developed a ferritin-based nanoparticle vaccine for PEDV by combining gene delivery functions of recombinant adenoviruses. To generate nanoparticles, the S1 subunit of the spike protein was genetically linked to the N-terminus of the human ferritin heavy chain (hFTHC), and recombinant adenoviruses were generated to deliver the genetic material. The efficacy of S1 conjugated human ferritin heavy chain (S1-hFTHC) adenoviruses against S1 adenoviruses was evaluated in BALB/c mice immunized intramuscularly without adjuvant. Two weeks after the final boost, we observed a significantly higher IgG response in S1-hFTHC immunized mice compared with the S1 immunized mice, and results from the virus neutralization assay revealed robust virus neutralization activity in the S1-hFTHC immunized group compared to the S1 immunized group. Furthermore, analysis of the serum based on IgG and neutralizing titers 40 days after the last vaccination revealed the significance and longevity of the immune response induced by S1-hFTCH compared to S1 only. This strategy elucidates the efficacy of combined vaccine strategies for developing promising vaccine candidates against PEDV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Infectious Diseases, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
- CellEnVax Co., Ltd, Republic of Korea.
- Laboratory of Infectious Diseases, College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea. Electronic address: shin0089@cnu.ac.kr.
Förderung
- Ministry of SMEs and Startups
- National Research Foundation of Korea
Zitieren
APA
Sudaraka Tennakoon, M. S. B. W. T. M. N., Park, J. Y., Lee, H. M., Ryu, J. H., & Shin, H. J. (2025). Ferritin nanoparticle complex with porcine epidemic diarrhea virus spike protein induces neutralizing antibody response against PEDV in mouse models. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107509
Vancouver
Sudaraka Tennakoon MSBWTMN, Park JY, Lee HM, Ryu JH, Shin HJ. Ferritin nanoparticle complex with porcine epidemic diarrhea virus spike protein induces neutralizing antibody response against PEDV in mouse models. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107509
BibTeX
@article{SudarakaTennakoon2025,
author = {Sudaraka Tennakoon, M S B W T M Nipuna and Park, Jae-Yeon and Lee, Hye-Mi and Ryu, Ji-Hoon and Shin, Hyun-Jin},
title = {Ferritin nanoparticle complex with porcine epidemic diarrhea virus spike protein induces neutralizing antibody response against PEDV in mouse models},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107509}
}
EUVIMED